Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brady Bernard

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Cancer Immunology Research|April 6, 2021
Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic RegimensVenkatesh Rajamanickam, Carmen Ballesteros-Merino, Kimberly Samson, et al.
Cell Systems|July 19, 2016
Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network AnalysisChristopher L Plaisier, Sofie O'Brien, Brady Bernard, et al.
The Journal of Clinical Investigation|April 19, 2022
PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumorsRebekka Duhen, Olivier Fesneau, Kimberly A Samson, et al.
Frontiers in Oncology|June 25, 2021
A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 TherapyIsaac Kim, Venkatesh Rajamanickam, Brady Bernard, et al.
Oncoimmunology|May 13, 2026
Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)Rachel E Sanborn, Shawn M Jensen, Christopher Paustian, et al.
NPJ Precision Oncology|July 2, 2025
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patternsNarmeen Daher-Ghanem, Shay Sharon, Derrick Tao, et al.
Frontiers in Oncology|January 19, 2024
Case report: <i>ex vivo</i> tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinomaMarwah Al-Aloosi, Amanda M Prechtl, Payel Chatterjee, et al.
Breast Cancer Research : BCR|January 8, 2021
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerKatherine Sanchez, Isaac Kim, Brie Chun, et al.
Plos One|September 1, 2020
Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancerBrady Bernard, Venkatesh Rajamanickam, Christopher Dubay, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progressionKristen M Turner, Youting Sun, Ping Ji, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cancer Immunology Research|April 6, 2021
Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic RegimensVenkatesh Rajamanickam, Carmen Ballesteros-Merino, Kimberly Samson, et al.
Cell Systems|July 19, 2016
Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network AnalysisChristopher L Plaisier, Sofie O'Brien, Brady Bernard, et al.
The Journal of Clinical Investigation|April 19, 2022
PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumorsRebekka Duhen, Olivier Fesneau, Kimberly A Samson, et al.
Frontiers in Oncology|June 25, 2021
A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 TherapyIsaac Kim, Venkatesh Rajamanickam, Brady Bernard, et al.
Oncoimmunology|May 13, 2026
Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)Rachel E Sanborn, Shawn M Jensen, Christopher Paustian, et al.
NPJ Precision Oncology|July 2, 2025
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patternsNarmeen Daher-Ghanem, Shay Sharon, Derrick Tao, et al.
Frontiers in Oncology|January 19, 2024
Case report: <i>ex vivo</i> tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinomaMarwah Al-Aloosi, Amanda M Prechtl, Payel Chatterjee, et al.
Breast Cancer Research : BCR|January 8, 2021
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerKatherine Sanchez, Isaac Kim, Brie Chun, et al.
Plos One|September 1, 2020
Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancerBrady Bernard, Venkatesh Rajamanickam, Christopher Dubay, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progressionKristen M Turner, Youting Sun, Ping Ji, et al.
Pageof 4